Aude G Chapuis Olga K Afanasiev Jayasri G Iyer Kelly G Paulson Upendra Parvathaneni Joo Ha Hwang Ivy Lai Ilana M Roberts Heather L Sloan Shailender Bhatia Kendall C Shibuya Ted Gooley Cindy Desmarais David M Koelle Cassian Yee Paul Nghiem
10.1158/2326-6066.CIR-13-0087
Cancer Immunol Res
2014 Jan;2(1):27-36.
author_manuscript
https://pubmed.ncbi.nlm.nih.gov/24432305/
Carcinoma, Merkel Cell / immunology Carcinoma, Merkel Cell / therapy Histocompatibility Antigens Class I / immunology Immunotherapy, Adoptive Skin Neoplasms / immunology Skin Neoplasms / therapy T-Cell Antigen Receptor Specificity / immunology T-Lymphocyte Subsets / immunology
Carcinoma, Merkel Cell / immunology Carcinoma, Merkel Cell / therapy Histocompatibility Antigens Class I / immunology Immunotherapy, Adoptive Skin Neoplasms / immunology Skin Neoplasms / therapy T-Cell Antigen Receptor Specificity / immunology T-Lymphocyte Subsets / immunology Case Reports Aged Antigens, Polyomavirus Transforming / immunology Antigens, Polyomavirus Transforming / metabolism Carcinoma, Merkel Cell / diagnosis Carcinoma, Merkel Cell / pathology Down-Regulation Histocompatibility Antigens Class I / metabolism Humans Immunohistochemistry Male Merkel cell polyomavirus / immunology Neoplasm Metastasis Skin Neoplasms / diagnosis Skin Neoplasms / pathology T-Lymphocytes, Cytotoxic / immunology Treatment Outcome Antigens, Polyomavirus Transforming Histocompatibility Antigens Class I
PMC3888869
24432305
Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-I
2014